Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
19,662,301
-
Share change
-
-969,610
-
Total reported value
-
$95,752,005
-
Put/Call ratio
-
70%
-
Price per share
-
$4.87
-
Number of holders
-
53
-
Value change
-
-$3,805,434
-
Number of buys
-
18
-
Number of sells
-
24
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q2 2021
As of 30 Jun 2021 Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) had 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,662,301 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, Carmignac Gestion, ACT Capital Management, LLC, VANGUARD GROUP INC, ACUTA CAPITAL PARTNERS, LLC, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This table shows 53 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.